{'fraction_non_alphanumeric': 0.025089605734767026, 'fraction_numerical': 0.0035842293906810036, 'mean_word_length': 5.446153846153846, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Preparation of HR magnetic IONPs for drug delivery

Hypoxia is a common phenomenon in the majority of solid tumours, thereby contributing to progression, angiogenesis, invasion, and metastasis of tumours. The authors synthesised a hypoxia-responsive (HR) magnetic iron oxide nanoparticles (IONPs) as drug delivery system by incorporating a hypoxia moiety (azobenzene) between IONPs and drug. The obtained drug delivery system showed sustained release under normoxic conditions, while a controlled release was observed under hypoxic condition due to the cleavage of azobenzene. More than 80% of the drug was released in 4 h after hypoxic treatment, leading to a high cytotoxicity. Thus, this HR magnetic drug delivery system had the potential for future applications in the treatment of hypoxic tumours and other hypoxia-related diseases.